Journal of Cystic Fibrosis
Volume 4, Issue 3 , Pages 197-201 , September 2005

Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES)

Received 20 January 2005 ,Revised 2 February 2005 ,Accepted 17 May 2005.

References 

  1. Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol. 2005 (Jan);39(1):15–20
  2. Drew J, Watson AR, Smyth A. Acute renal failure and cystic fibrosis. Arch Dis Child. 2003;88:646
  3. Kovesi TA, Swartz R, MacDonald N. Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis. N Engl J Med. 1998;338:65–66
  4. Hinshaw HC, Feldman WH. Streptomycin in the treatment of tuberculosis: a preliminary report. Mayo Clin Proc. 1945;20:313–318
  5. Rey E, Treluyer J-M, Pons G. Drug disposition in cystic fibrosis. Clin Pharmacokinet. 1998;35:313–329
  6. Drew JH, Watson AR, Evans JH, Smyth AR. Antibiotics and acute renal failure in children with cystic fibrosis. Paediat Perinat Drug Ther. 2002;5:65–67
  7. Burkle WS. Is tobramycin less nephrotoxic than gentamicin?. Clin Pharm. 1986;5:514–516
  8. Pedersen SS, Jensen T, Osterhammel D, Osterhammel P. Cumulative and acute toxicity of repeated high dose tobramycin treatment in cystic fibrosis. Antimicrob Agents Chemother. 1987;31:594–599
  9. Mingeot-Lecleroq Mp, Tulkens PM. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother. 1999;43:1003–1012
  10. Mirakhur A, Gallagher MJ, Ledson MJ, Hart CA, Walshaw MJ. Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis. J Cyst Fibros. 2003;2:19–24
  11. Antibiotic treatment for cystic fibrosis. In: Report of the UK cystic fibrosis trust antibiotic group. Second edition. 2002 (September);
  12. Pusey CD, Saltissi D, Bloodworth L, Rainford DJ, Christie JL. Drug associated acute interstitial nephritis: clinical and pathological features and the response to high dose steroid therapy. Q J Med. 1983;52:194–211
  13. Stephens SE, Rigden SPA. Cystic fibrosis and renal disease. Paediatr Respir Rev. 2002;3:135–138
  14. Mansoor GA, Panner BJ, Ornt DB. Azithromycin-induced acute interstitial nephritis. Ann Intern Med. 1993;119:636–637
  15. Hoffler D, Koeppe P, Paeske B. Pharmacokinetics of azithromycin in normal and impaired renal function. Infection. 1995;23:356–361
  16. Grunden JW, Fisher KA. Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin. Ann Pharmacother. 1997;3:859–863
  17. Ljutic D, Rumboldt Z. Possible interaction between azithromycin and cyclosporin: a case report. Nephron. 1995;70:130
  18. Scott CS, Retsch-Bogart GZ, Henry MM. Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen. Pediatr Pulmonol. 2001 (Apr);31:314–316
  19. Whelton A. Renal effects of over-the-counter analgesics. J Clin Pharmacol. 1995;35:454–463
  20. Scott F, Pitt T. Identification and characterisation of transmissible Pseudomonas aeruginosa strains in cystic fibrosis centres in Great Britain. Pediatr Pulmonol. 2003;307(supplement 25):A356
  21. Elborn JS, Prescott RJ, Stack BH, Goodchild MC, Bates J, Pantin C, et al. Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Thorax. 2000 (May);55(5):355–358

PII: S1569-1993(05)00075-5

doi: 10.1016/j.jcf.2005.05.017

Journal of Cystic Fibrosis
Volume 4, Issue 3 , Pages 197-201 , September 2005

Article Tools